Jennifer H. Anolik, M.D., Ph.D.

Jennifer H. Anolik, M.D., Ph.D.

Contact Information

University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave., Box 695
Rochester, NY 14642

Office: (585) 275-1632
Fax: (585) 442-3214
Administrative: (585) 273-3213
Lab: (585) 273-2179

Journal Articles

Showing all 56 journal articles available.

2014
Wang W, Rangel-Moreno J, Owen T, Barnard J, Nevarez S, Ichikawa HT, Anolik JH. "Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche." The Journal of immunology : official journal of the American Association of Immunologists. 2014 192(7):3011-20. Epub 2014 Feb 26.
2014
Palanichamy A, Bauer JW, Yalavarthi S, Meednu N, Barnard J, Owen T, Cistrone C, Bird A, Rabinovich A, Nevarez S, Knight JS, Dedrick R, Rosenberg A, Wei C, Rangel-Moreno J, Liesveld J, Sanz I, Baechler E, Kaplan MJ, Anolik JH. "Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus." The Journal of immunology : official journal of the American Association of Immunologists. 2014 192(3):906-18. Epub 2013 Dec 30.
2011
Marcus C, Dhillon G, Anolik JH. "B cell immunology for the clinician." The Pediatric infectious disease journal. 2011 30(2):158-60.
2010
Bekar KW, Owen T, Dunn R, Ichikawa T, Wang W, Wang R, Barnard J, Brady S, Nevarez S, Goldman BI, Kehry M, Anolik JH. "Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus." Arthritis and rheumatism. 2010 62(8):2443-57.
2010
Marston B, Palanichamy A, Anolik JH. "B cells in the pathogenesis and treatment of rheumatoid arthritis." Current opinion in rheumatology. 2010 22(3):307-15.
2010
Ahmed S, Anolik JH. "B-cell biology and related therapies in systemic lupus erythematosus." Rheumatic diseases clinics of North America. 2010 36(1):109-30, viii-ix.
2009
Palanichamy A, Barnard J, Zheng B, Owen T, Quach T, Wei C, Looney RJ, Sanz I, Anolik JH. "Novel human transitional B cell populations revealed by B cell depletion therapy." The Journal of immunology : official journal of the American Association of Immunologists. 2009 182(10):5982-93.
2009
Palanichamy, A.; Barnard, J.; Zheng, B.; Owen, T.; Quach, T.; Wei, C.; Looney, R.J.; Sanz, I.; Anolik, J.H. "Novel populations of human transitional B cells revealed by B cell depletion therapy". Journal of Immunology. 2009; . Link
2009
Coca, A.; Anolik, J. "Two negative randomized controlled trials in lupus: now what? Faculty of 1000 invited commentary". 2009; . Link
2009
Anolik, J.; Looney, R.J.; Lund, F.; Randall, T.; Sanz, I. "Insights into the heterogeneity of human B cells: diversefunctions, roles in autoimmunity, and use as therapeutic targets". Immunologic Research. 2009; . Link
2009
Anolik JH, Looney RJ, Lund FE, Randall TD, Sanz I. "Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets." Immunologic research. 2009 45(2-3):144-58. Epub 2009 Apr 07.
2008
Coca A, Anolik JH. "Targeted biologic approaches to the treatment of systemic vasculitis." Clinical reviews in allergy & immunology. 2008 35(1-2):79-87.
2008
Mehta LR, Samuelsson MK, Kleiner AK, Goodman AD, Anolik JH, Looney RJ, Schwid SR. "Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome." Multiple sclerosis : clinical and laboratory research. 2008 14(3):425-7. Epub 2008 Jan 21.
2008
Sanz I, Wei C, Lee FE, Anolik J. "Phenotypic and functional heterogeneity of human memory B cells." Seminars in immunology. 2008 20(1):67-82. Epub 2008 Feb 06.
2008
Anolik JH, Ravikumar R, Barnard J, Owen T, Almudevar A, Milner EC, Miller CH, Dutcher PO, Hadley JA, Sanz I. "Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks." The Journal of immunology : official journal of the American Association of Immunologists. 2008 180(2):688-92.
2008
Walker, AR.; Kleiner, A.; Rich, L.; Conners, C.; Fisher, RI.; Anolik, JH.; Friedberg, JW. "Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma". Cancer Investigations. 2008; 26(4): 431-433. Link
2008
Coca, A.; Anolik, J. "Targeted Biologic Approaches to the Treatment of Systemic Vasculitis". Clinic Reviews in Allergy and Immunology. 2008; 35: 79. Link
2007
Anolik JH, Barnard J, Owen T, Zheng B, Kemshetti S, Looney RJ, Sanz I. "Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy." Arthritis and rheumatism. 2007 56(9):3044-56.
2007
Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, Lee EH, Milner EC, Sanz I. "A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus." The Journal of immunology : official journal of the American Association of Immunologists. 2007 178(10):6624-33.
2007
Anolik JH, Friedberg JW, Zheng B, Barnard J, Owen T, Cushing E, Kelly J, Milner EC, Fisher RI, Sanz I. "B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny." Clinical immunology : the official journal of the Clinical Immunology Society. 2007 122(2):139-45. Epub 2006 Sep 27.
2007
Ravikumar, R.; Anolik, JH.; Looney, RH. "Vaccine responses in patients with rheumatoid arthritis". Current Rheumatoloy Reports. 2007; 9: 407-415. Link
2007
Anolik, JH. "B cell biology and dysfunction in SLE". Bulliten of the New York University Hospital of Joint Disease. 2007; 65: 182-186. Link
2007
Sanz I, Anolik JH, Looney RJ. "B cell depletion therapy in autoimmune diseases." Frontiers in bioscience : a journal and virtual library. 2007 12:2546-67. Epub 2007 Jan 01.
2007
Anolik JH. "B cell biology and dysfunction in SLE." Bulletin of the NYU hospital for joint diseases. 2007 65(3):182-6.
2006
Looney RJ, Anolik J, Sanz I. "New therapies for systemic lupus erythematosus: cellular targets." Rheumatic diseases clinics of North America. 2006 32(1):201-15, xi.
2006
Sabahi, R.; Anolik, JH. "B cell targeted therapy for systemic lupus eryethematosus". Drugs. 2006; 66: 1. Link
2006
Sabahi R, Anolik JH. "B-cell-targeted therapy for systemic lupus erythematosus." Drugs. 2006 66(15):1933-48.
2005
Cappione A, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, Silverman G, Sanz I. "Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus." The Journal of clinical investigation. 2005 115(11):3205-16. Epub 2005 Oct 06.
2005
Anolik JH, Aringer M. "New treatments for SLE: cell-depleting and anti-cytokine therapies." Best practice & research. Clinical rheumatology. 2005 19(5):859-78.
2005
Milner EC, Anolik J, Cappione A, Sanz I. "Human innate B cells: a link between host defense and autoimmunity?" Springer seminars in immunopathology. 2005 26(4):433-52. Epub 2005 Jan 05.
2005
Anolik, JH.; Aringer, M. "New treatments for SLE: Cell -depleting and anti-cytokine therapies". Best Practices and Research Clinical Rheumatology. 2005; 19(5): 859. Link
2005
Sanz I, Anolik J. "Reconstitution of the adult B cell repertoire after treatment with rituximab." Arthritis research & therapy. 2005 7(5):175-6. Epub 2005 Jul 22.
2004
Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I. "Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus." Arthritis and rheumatism. 2004 50(11):3580-90.
2004
Anolik J, Sanz I. "B cells in human and murine systemic lupus erythematosus." Current opinion in rheumatology. 2004 16(5):505-12.
2004
Looney RJ, Anolik JH, Campbell D, Felgar RE, Young F, Arend LJ, Sloand JA, Rosenblatt J, Sanz I. "B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab." Arthritis and rheumatism. 2004 50(8):2580-9.
2004
Looney RJ, Anolik J, Sanz I. "B cells as therapeutic targets for rheumatic diseases." Current opinion in rheumatology. 2004 16(3):180-5.
2004
Cappione AJ, Pugh-Bernard AE, Anolik JH, Sanz I. "Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes." The Journal of immunology : official journal of the American Association of Immunologists. 2004 172(7):4298-307.
2004
Looney RJ, Anolik J, Sanz I. "B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells." Lupus. 2004 13(5):381-90.
2003
Anolik J, Sanz I, Looney RJ. "B cell depletion therapy in systemic lupus erythematosus." Current rheumatology reports. 2003 5(5):350-6.
2003
Anolik J, Looney RJ, Bottaro A, Sanz I, Young F. "Down-regulation of CD20 on B cells upon CD40 activation." European journal of immunology. 2003 33(9):2398-409.
2003
Anolik JH, Campbell D, Felgar RE, Young F, Sanz I, Rosenblatt J, Looney RJ. "The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus." Arthritis and rheumatism. 2003 48(2):455-9.
2001
Anolik JH, Blumberg N, Snider J, Francis CW. "Posttransfusion purpura secondary to an alloantibody reactive with HPA-5a (Br(b))." Transfusion. 2001 41(5):633-6.
2001
Anolik JH, Wildy K, Cohn SE, Marquardt JD, Totterman S, Zwillich SH. "Multifocal Staphylococcus aureus infection originating from the sacroiliac joint in a patient with rheumatoid arthritis." The Journal of rheumatology. 2001 28(1):217-20.
2000
Anolik, JH.; Ritchlin, C. "A 40 year old woman with destructive arthritis and severe interstitial lung disease". AML Interactions. 2000; . Link
1998
Anolik JH, Di Giovanna JJ, Gaspari AA. "Effect of isotretinoin therapy on natural killer cell activity in patients with xeroderma pigmentosum." The British journal of dermatology. 1998 138(2):236-41.
1997
Sathya G, Li W, Klinge CM, Anolik JH, Hilf R, Bambara RA. "Effects of multiple estrogen responsive elements, their spacing, and location on estrogen response of reporter genes." Molecular endocrinology. 1997 11(13):1994-2003.
1996
Anolik JH, Klinge CM, Brolly CL, Bambara RA, Hilf R. "Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors." The Journal of steroid biochemistry and molecular biology. 1996 59(5-6):413-29.
1995
Anolik,J. H.; Klinge,C. M.; Hilf,R.; Bambara,R. A. "Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand". Biochemistry (John Wiley & Sons). 1995; 34(8): 2511,2520. Link
1994
Anolik, JA. "Estrogen receptor interaction with estrogen response element (ERE) DNA: Role of ligand, ERE spacing, flanking sequences". 1994; . Link
1993
Anolik JH, Klinge CM, Bambara RA, Hilf R. "Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA." The Journal of steroid biochemistry and molecular biology. 1993 46(6):713-30.
1990
Shinnar, AE.; Anolik, JH.; Johnson, DA.; Lobl, TJ. "Physical and conformational properties of a synthetic leader peptide from bovine serum albumin". Proceedings of the Eleventh American Peptide Symposium. 1990; . Link
0
Palanichamy, A.; Barnard, J.; Zheng, B.; Wei, C.; Owen, T.; Cushing, E.; Campbell, D.; Kemshetti, S.; Looney, R.J.; Sanz, I.; Anolik, J.H. "Expansion of transitional B cells in human SLE". In Preperation. . Link
0
Bekar, K.; Owen, T.; Dunn, R.; Kehry, M.; Anolik, J.H. "Treatment with anti-CD20 prevents and reverses murine lupus". In preparation. . Link
0
Sabahi, R.; Owen, T.; Barnard, J.; Cushing, E.; Looney, R.J.; Sanz, I.; Anolik, J.H. "Immunologic effects of BAFF antagonism in the treatment of human SLE". In preparation. . Link
0
Barnard, J.; Palanichamy, A.; Bauer, J.W.; Koeuth, T.; Baechler, E.C.; Anolik, J.H. "Interferon activation in human SLE bone marrow inhibits B cell lymphopoeisis". In preparation. . Link
0
Wang, R.; Owen, T.; Bekar, K.; Anolik, J. "TLR9 stimulation adversely impacts B cell depletion and reconstitution in the mouse". In preparation. . Link